GT Biopharma Reports Second Quarter 2026 Financial Results

Go back to GT Biopharma Reports Second Quarter 2026 Financial Results
(NASDAQ: GTBP) Delayed: 0.28 -0.01 (3.45%)
Previous Close $0.29    52 Week High
Open $0.29    52 Week Low
Day High $0.29    P/E N/A 
Day Low $0.27    EPS
Volume 536,008